Research Article
There Is No Impact of Diabetes on the Endothelial Function of Chronic Kidney Disease Patients
Table 3
Endothelial dysfunction markers in CKD and CKD-DM groups.
| | CKD group () | CKD-DM group () | |
| FMD, % | 2.68 ± 3.11 | 2.95 ± 3.69 | 0.737 | NMD, % | 11.51 ± 6.05 | 9.26 ± 5.47 | 0.104 | EPC, % | 0.25 (0.1–0.6) | 0.60 (0.3–0.9) | 0.009 | SDF-1α, pg/ml | 3730 (2915–4830) | 3430 (2695–4770) | 0.699 | Serum nitric oxide, μmol/l | 390.5 (296.5–568.8) | 387.5 (241.5–613.8) | 0.641 | 24 h urinary nitric oxide, μmol | 3432 (1593–5521) | 3336 (1213–5896) | 0.734 |
|
|
FMD = flow-mediated dilation; NMD = nitrate-mediated dilation; EPC = endothelial progenitor cell; SDF-1α = stromal cell-derived factor 1.
|